PATENT CLAIM ANALYSIS

Application Number: 15942321
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "210020"]

Abstract:
Naphthyridine compounds and their use as inhibitors of HPK1 are described. The compounds are useful in treating HPK1-dependent disorders and enhancing an immune response. Also described are methods of inhibiting HPK1, methods of treating HPK1-dependent disorders, methods for enhancing an immune response, and methods for preparing the naphthyridine compounds.

Claim (Index 43):
The compound of  claim 36 , wherein D is wherein Q is NR 20 , O or S;\n X is CR 38a R 38b , NR 36 , S or O; \n X\u2032 is CR 39a R 39b , NR 36 , S, SO 2  or O; \n R 36 , R 37a , R 37b , R 38a  and R 38b  are independently hydrogen or R 30 ; \n R 39a  and R 39b  are independently hydrogen or R 30 , or R 39a  and R 39b  are taken together with the carbon atom to which they are attached to form a C 3-7  cycloalkyl or C 3-7  heterocyclyl; and \n R 20  and R 30  are as defined in  claim 36 .

Metadata:
- Claim Count in Document: 140.0
- Percentile: 90.0
- Lexical Diversity: 1.83333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12530648', '13102720', '15281923', '13266976', '15852639']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7588896252716733
- 35 USC 102 Novelty (BERT): 0.5195618799917329
- Combined Prediction Score: 0.7349568507436792
- Mean Citation Score: 269.39763800000003
- Max Citation Score: 276.27457000000004
- Similarity Product: 186.95160815939423

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test